Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

P53: A Guardian of Immunity Becomes Its Saboteur through Mutation
Arjelle Decasa Agupitan, Paul J. Neeson, Scott Williams, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 10, pp. 3452-3452
Open Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

Targeting p53 pathways: mechanisms, structures and advances in therapy
Haolan Wang, Ming Guo, Hudie Wei, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 379
p53 signaling in cancer progression and therapy
Hany E. Marei, Asmaa Althani, Nahla Afifi, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 378
The Regulation of Ferroptosis by Tumor Suppressor p53 and its Pathway
Juan Liu, Cen Zhang, Jianming Wang, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8387-8387
Open Access | Times Cited: 196
Emerging Function and Clinical Values of Exosomal MicroRNAs in Cancer
Man Wang, Fei Yu, Han Ding, et al.
Molecular Therapy — Nucleic Acids (2019) Vol. 16, pp. 791-804
Open Access | Times Cited: 172
Translating p53-based therapies for cancer into the clinic
Sylvain Peuget, Xiaolei Zhou, Galina Selivanova
Nature reviews. Cancer (2024) Vol. 24, Iss. 3, pp. 192-215
Closed Access | Times Cited: 56
Targeting p53 for Immune Modulation: Exploring Its Functions in Tumor Immunity and Inflammation
Hong Wu, Sarah Leng, David D. Eisenstat, et al.
Cancer Letters (2025), pp. 217614-217614
Closed Access | Times Cited: 2
The Role of p53 Dysfunction in Colorectal Cancer and Its Implication for Therapy
Maurice Stephan Michel, Leonard Kaps, Annett Maderer, et al.
Cancers (2021) Vol. 13, Iss. 10, pp. 2296-2296
Open Access | Times Cited: 81
Improving cancer immunotherapy by rationally combining oncolytic virus with modulators targeting key signaling pathways
Zhi Zhu, A. J. Robert McGray, Weijian Jiang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 60
Neuroinflammation in Ischemic Stroke: Focus on MicroRNA-mediated Polarization of Microglia
Lu Lian, Yunsha Zhang, Lu Liu, et al.
Frontiers in Molecular Neuroscience (2021) Vol. 13
Open Access | Times Cited: 57
The role of p53 in anti-tumor immunity and response to immunotherapy
Lindsey Carlsen, Shengliang Zhang, Xiaobing Tian, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 37
The Wheel of p53 Helps to Drive the Immune System
Barbara Łasut-Szyszka, Marek Rusin
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7645-7645
Open Access | Times Cited: 25
p53 at the crossroads of tumor immunity
Gizem Efe, Anil K. Rustgi, Carol Prives
Nature Cancer (2024) Vol. 5, Iss. 7, pp. 983-995
Closed Access | Times Cited: 15
Potential role of p53 deregulation in modulating immune responses in human malignancies: A paradigm to develop immunotherapy
Shivi Chauhan, Shivani Jaiswal, Vibhuti Jakhmola, et al.
Cancer Letters (2024) Vol. 588, pp. 216766-216766
Open Access | Times Cited: 12
TP53 to mediate immune escape in tumor microenvironment: an overview of the research progress
Kaili Zhu, Fei Su, Jingru Yang, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Open Access | Times Cited: 10
Insights on E1-like enzyme ATG7: functional regulation and relationships with aging-related diseases
Jingwei Liu, Yutong Xiao, Liangzi Cao, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 8
The Role of p53 in Progression of Cutaneous Squamous Cell Carcinoma
Minna Piipponen, Pilvi Riihilä, Liisa Nissinen, et al.
Cancers (2021) Vol. 13, Iss. 18, pp. 4507-4507
Open Access | Times Cited: 53
Targeting Mutant p53 for Cancer Treatment: Moving Closer to Clinical Use?
Michael J. Duffy, Minhong Tang, Subhasree Rajaram, et al.
Cancers (2022) Vol. 14, Iss. 18, pp. 4499-4499
Open Access | Times Cited: 34
Cancer-associated inflammation: pathophysiology and clinical significance
Piotr Pęczek, Monika Gajda, Kacper Rutkowski, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 149, Iss. 6, pp. 2657-2672
Open Access | Times Cited: 33
Impact of TP53 on outcome of patients with myelofibrosis undergoing hematopoietic stem cell transplantation
Nico Gagelmann, Anita Badbaran, Rachel B. Salit, et al.
Blood (2023)
Open Access | Times Cited: 17
Sculpting tumor microenvironment with immune system: from immunometabolism to immunoediting
Y-R Yu, Ping‐Chih Ho
Clinical & Experimental Immunology (2019) Vol. 197, Iss. 2, pp. 153-160
Open Access | Times Cited: 51
Tumor suppressor p53 cross-talks with TRIM family proteins
Juan Liu, Cen Zhang, Xue Wang, et al.
Genes & Diseases (2020) Vol. 8, Iss. 4, pp. 463-474
Open Access | Times Cited: 44
Mutant p53 in cell-cell interactions
Steven E. Pilley, Tristan A. Rodríguez, Karen H. Vousden
Genes & Development (2021) Vol. 35, Iss. 7-8, pp. 433-448
Open Access | Times Cited: 39
Promising New Tools for Targeting p53 Mutant Cancers: Humoral and Cell-Based Immunotherapies
Vitaly Chasov, Mikhail M. Zaripov, Regina Mirgayazova, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 35
Molecular Mechanisms of Anti-Neoplastic and Immune Stimulatory Properties of Oncolytic Newcastle Disease Virus
Volker Schirrmacher
Biomedicines (2022) Vol. 10, Iss. 3, pp. 562-562
Open Access | Times Cited: 28
p53/NF-kB Balance in SARS-CoV-2 Infection: From OMICs, Genomics and Pharmacogenomics Insights to Tailored Therapeutic Perspectives (COVIDomics)
Daniela Milani, Lorenzo Caruso, Enrico Zauli, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 27
Page 1 - Next Page

Scroll to top